Skip to content

The Outcomes of Keystone Perforator Island Flap Versus Lay Open in Re-recurrent Pilonidal Sinus Disease

The Outcomes of Keystone Perforator Island Flap Versus Lay Open in Re-recurrent Pilonidal Sinus Disease ( Two Times of Recurrence or More): One Year Experience Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06741449
Enrollment
24
Registered
2024-12-19
Start date
2024-02-01
Completion date
2025-02-01
Last updated
2025-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilonidal Sinus Treatment

Brief summary

Pilonidal disease is a common and annoying problem with a fair recurrence rate. Every time of recurrence more skin is needed to cover the defect and if left open healing is supposed to be prolonged.

Interventions

PROCEDUREkeystone flap

facio-cutaneous flap used to cover the defect after removal of the disease

PROCEDURElay open

after removal of the disease, the wound is left open to heal by granulation tissue

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* re-recurrent pilonidal disease

Exclusion criteria

* patients with proved anal or perineal malignancy or autoimmune disease * patient with pilonidal disease for the first time or for the first time of recurrence

Design outcomes

Primary

MeasureTime frameDescription
operative timeoperative time is measured in minutes from incision to wound dressing
bleeding amountamount of blood lost is measured from incision for 2 days post operativeintra and post operative bleeding amount is measured in cc by volumetric method
healing timehealing time is measured for 3 months post-operatively
wound infectionwound infection is evaluated for 3 months post-operativelywound infection evaluated by presence of pus from the first day post-operativel

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026